Intended for healthcare professionals

Letters Semaglutide and risk of major cardiovascular events

Semaglutide reduces the absolute risk of major cardiovascular events by 1.5%

BMJ 2024; 384 doi: https://doi.org/10.1136/bmj.q53 (Published 15 January 2024) Cite this as: BMJ 2024;384:q53

Article usage

Article metrics provide readers and authors with an indication of how often a specific article has been accessed month by month. It counts three formats - abstract/extract, full text and pdf. The page is updated each day.

Usage statistics: January 2024 to September 2024

Rendering graph...
AbstractFullPdf
Jan 2024140917072
Feb 20249026012
Mar 20249758419
Apr 20241147515
May 20245876814
Jun 20244504613
Jul 20244054911
Aug 20244284415
Sep 2024146143
Total6449586164